G-BA Revises AKI Guidelines to Ease Physician Burden and Ensure Patient Care
The Joint Federal Committee (G-BA) has introduced significant amendments to the out-of-hospital intensive care (AKI) guidelines, aiming to streamline potential assessments and adapt to...
Robotic Surgery Proves Superior in Cancer Operations, Study Finds
A groundbreaking meta-analysis published in the Annals of Surgery highlights the significant benefits of robotic surgery over traditional laparoscopic and open methods in seven...
Incyte’s Retifanlimab Enhances Survival in NSCLC Patients During Phase 3 Trial
Incyte announced that its Phase 3 POD1UM-304 trial demonstrated significant improvements in overall survival when retifanlimab (Zynyz) was combined with platinum-based chemotherapy for patients...
Canada Drug Agency Initiates Efforts Under New Pharmacare Legislation
Canada's Drug Agency has embarked on a strategic initiative following the royal assent of An Act respecting pharmacare on October 10, 2024. Responding to...
Germany Revamps Rheumatoid Arthritis Program to Address Care Gaps
Germany is undertaking a significant update to its Disease Management Program (DMP) for rheumatoid arthritis (RA), aiming to align it more closely with the...
German Health Committee Details 2025 System Surcharge Rates
The Gemeinsamer Bundesausschuss unveiled the system surcharge figures for 2025, outlining precise rates applicable across several healthcare sectors. This strategic move aims to streamline...
Datopotamab Deruxtecan Achieves High Response Rate in Advanced EGFR-Mutated NSCLC Patients
In a significant advancement for non-small cell lung cancer (NSCLC) treatment, Datopotamab Deruxtecan demonstrated a substantial 42.7% objective response rate in patients with previously...
Pharmaceutical Industry Expresses Concerns Over 2025 EU Advisory Meeting Shortfall
Pharmaceutical innovators have raised alarms about the limited number of advice meetings scheduled for 2025 under the new EU health technology assessment regulations. This...
GSK, Zhifei Extend Shingrix Collaboration, Eye RSV Vaccine in China
GSK plc has strengthened its alliance with Chongqing Zhifei Biological Products, securing the commercialization of the Shingrix vaccine in mainland China until 2034. This...
Pixavir Marboxil Capsules Show Promising Results in Recent Trials
Pixavir Marboxil Capsules have emerged as a potential breakthrough in the treatment of chronic respiratory conditions. Recent clinical trials conducted on a diverse group...
2021 Data Shows Increasing Maternal Health Disparities in Medicaid and CHIP
The latest Maternal Health Equity Data Brief reveals concerning trends in maternal health among Medicaid and CHIP enrollees aged 15 to 49. Analyzing data...
Lundbeck Showcases Bexicaserin for Rare Epilepsies at AES Annual Meeting
Lundbeck, through its subsidiary Longboard Pharmaceuticals, is set to present groundbreaking data on bexicaserin, a promising treatment for Developmental and Epileptic Encephalopathies (DEEs), at...
HHS Launches Comprehensive Global Health Strategy Emphasizing Equity and Collaboration
The U.S. Department of Health and Human Services (HHS) has unveiled a groundbreaking Global Strategy designed to elevate health equity and strengthen international partnerships....
Terumo Enhances Radial Access with R2P NaviCross Catheter Launch
Terumo Interventional Systems (TIS), a division of Terumo Corporation, has introduced the R2P NaviCross peripheral support catheter to the U.S. market. This strategic launch...
Welsh Government Launches Comprehensive Hub on Sodium Valproate for Women
Welsh authorities have introduced a new dedicated platform aimed at providing extensive information on the use of sodium valproate among women and girls. This...
